{"id":4243,"date":"2022-12-05T12:47:44","date_gmt":"2022-12-05T17:47:44","guid":{"rendered":"https:\/\/my.vanderbilt.edu\/vinsenews\/?p=4243"},"modified":"2022-12-05T12:47:44","modified_gmt":"2022-12-05T17:47:44","slug":"vinse-faculty-member-dr-james-crowe-wins-time-best-invention-of-2022","status":"publish","type":"post","link":"https:\/\/my.vanderbilt.edu\/vinsenews\/2022\/12\/vinse-faculty-member-dr-james-crowe-wins-time-best-invention-of-2022\/","title":{"rendered":"VINSE Faculty Member Dr. James Crowe wins ‘TIME’ Best Invention of 2022"},"content":{"rendered":"

Two Vanderbilt faculty who conducted translational research have received the distinction of Best Invention of 2022 from\u00a0<\/span>TIME<\/span><\/i>\u00a0magazine.<\/span>\u00a0<\/span><\/p>\n

\"\"
TIME\u2019s Best Inventions of 2022 Cover<\/figcaption><\/figure>\n

\u201cThese winning innovations exemplify the transformative potential of university research when it aims to solve society\u2019s most urgent problems, and when universities partner with the broader innovation ecosystem to bring new solutions to market faster,\u201d Vanderbilt Chancellor Daniel Diermeier said. \u201cI congratulate Dr. Crowe and Professor Weimer and their teams on these life-saving, landmark accomplishments.\u201d<\/span>\u00a0<\/span>\u00a0<\/span><\/p>\n

Combating COVID-19<\/span><\/b>\u00a0<\/span><\/p>\n

Dr. James Crowe Jr.<\/span><\/a>, director of the Vanderbilt Vaccine Center at Vanderbilt University Medical Center, led the team that discovered a monoclonal antibody combination that protects against COVID-19. Optimized and developed by AstraZeneca, the monoclonal antibody combination called\u202f<\/span>Evusheld<\/span><\/a>\u00a0is the first treatment to protect adults and children 12 years and older who have compromised immune systems before exposure to the virus. Evusheld received emergency authorization from the FDA in December 2021.\u202fEvusheld also won a\u00a0<\/span>gold medal<\/span><\/a>\u00a0in the\u202f2022 R&D 100\u202fawards and the 2022\u202f<\/span>Harrington Prize<\/span><\/a>\u202ffor Innovation in Medicine.\u202f<\/span>\u00a0<\/span>\u00a0<\/span><\/p>\n

The VVC is an international team of scientists and physicians focusing on research related to major human pathogens, especially microbial threats, that affect the most vulnerable subjects. The VVC is committed to improving global health through fundamental research that fosters development and testing of new vaccines for infectious diseases.\u202f<\/span>\u00a0<\/span><\/p>\n

\u201cThese inventions, resulting from the groundbreaking research of Drs. Crowe and Weimer, represent the unique, trans-institutional approach to discovery that is a hallmark of Vanderbilt,\u201d said Dr. Jeff Balser, President and Chief Executive Officer for Vanderbilt University Medical Center and Dean of Vanderbilt University School of Medicine. \u201cAs we celebrate these achievements, it is fitting to reflect on the many lives being impacted by this research.”<\/span><\/p>\n

READ FULL ARTICLE HERE<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Two Vanderbilt faculty who conducted translational research have received the distinction of Best Invention of 2022 from\u00a0TIME\u00a0magazine.\u00a0 TIME\u2019s Best Inventions of 2022 Cover \u201cThese winning innovations exemplify the transformative potential of university research when it aims to solve society\u2019s most urgent problems, and when universities partner with the broader innovation ecosystem to bring new solutions…<\/p>\n","protected":false},"author":9492,"featured_media":4244,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[144,12,18],"class_list":["post-4243","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-james-crowe","tag-vinse-faculty-news","tag-vinse-news"],"_links":{"self":[{"href":"https:\/\/my.vanderbilt.edu\/vinsenews\/wp-json\/wp\/v2\/posts\/4243","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/my.vanderbilt.edu\/vinsenews\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/my.vanderbilt.edu\/vinsenews\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/my.vanderbilt.edu\/vinsenews\/wp-json\/wp\/v2\/users\/9492"}],"replies":[{"embeddable":true,"href":"https:\/\/my.vanderbilt.edu\/vinsenews\/wp-json\/wp\/v2\/comments?post=4243"}],"version-history":[{"count":2,"href":"https:\/\/my.vanderbilt.edu\/vinsenews\/wp-json\/wp\/v2\/posts\/4243\/revisions"}],"predecessor-version":[{"id":4246,"href":"https:\/\/my.vanderbilt.edu\/vinsenews\/wp-json\/wp\/v2\/posts\/4243\/revisions\/4246"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/my.vanderbilt.edu\/vinsenews\/wp-json\/wp\/v2\/media\/4244"}],"wp:attachment":[{"href":"https:\/\/my.vanderbilt.edu\/vinsenews\/wp-json\/wp\/v2\/media?parent=4243"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/my.vanderbilt.edu\/vinsenews\/wp-json\/wp\/v2\/categories?post=4243"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/my.vanderbilt.edu\/vinsenews\/wp-json\/wp\/v2\/tags?post=4243"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}